Chemicals & Advanced Materials Global On demand · 24-48h

Global Nucleic Acid Isolation and Purification Market Strategic Research Report

Global Nucleic Acid Isolation and Purification Market Strate…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Nucleic Acid Isolation and Purification Market
$5.28B2025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: DNA Isolation and Purification, RNA Isolation and Purification

By Application: Laboratory, Hospital, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, Danaher, PerkinElmer, Agilent, Promega, Bio-Rad, Takara Bio, Kurabo Biomedical, LGC Biosearch, Abcam, Bioneer, Meridian Bioscience, CW Bio, Xian Tianlong, Suzhou Yarui, Shengxiang, Shanghai Zhijiang

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 141 pages
Market size 2025
$5.28B
Billion USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$7.9B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Nucleic Acid Isolation and Purification market size is predicted to grow from US$ 5,278 million in 2025 to US$ 7,915 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

The isolation and purification of nucleic acid are among the basic tests in the molecular laboratory research, with the availability of a wide range of equipment and processes used for its extraction. Nucleic acid isolation and purification is a combination of chemical and physical processes involved in isolation of DNA or RNA. Nucleic acid isolation and purification used in many types of biological research including molecular biology, forensics, pathology, environmental research, and drug discovery. Nucleic acid isolation and purification is done to purify, amplify, or manipulate the nucleic acid to understand the complex details of biological systems. Nucleic acid extraction methods are routine procedures in molecular biology and are starting point of various downstream applications. The main aim for nucleic acid extraction and purification is to disintegrate the cell envelope through lysis and separate nucleic acid from proteins or lipids. Nucleic acid extraction is the primary step for any amplification experiment and is a crucial step in development and performance of any successful molecular diagnostic method. It consists of three major steps: isolation, purification, and concentration. This technique has brought a revolution in clinical diagnostics and has contributed to development of advanced diagnostic tools and tests. Features to look for in choosing an automated Nucleic Acid extraction system include integration with laboratory information management systems, full start-to-finish automation, error control, and safeguards against contamination. Extraction kits simplify the process of extraction by eliminating the need for mechanical disruption and by decreasing hands-on time. Moreover, enhanced protocols for specific samples deliver reproducible purification of high-quality DNA/RNA. In our report, one unit is one preps or one machine.

The growing demand for precise diagnostics, personalized medicine, and advancements in genetic research is a major driver for the nucleic acid isolation and purification market. As the need for accurate detection of genetic mutations, pathogens, and biomarkers rises, technologies for isolating and purifying DNA, RNA, and other nucleic acids are critical for molecular diagnostics, research, and drug development. The increasing prevalence of genetic disorders, infectious diseases, and cancer has led to a surge in research and clinical testing, further fueling the demand for reliable nucleic acid extraction methods. Additionally, technological advancements, such as automation, higher throughput systems, and more efficient kits, are improving the speed, sensitivity, and reproducibility of nucleic acid isolation, making these processes more accessible across laboratories and clinical settings.The key challenges in the nucleic acid isolation and purification market is the complexity and cost of the available technologies. While advancements have been made, current methods often require specialized equipment, skilled personnel, and can be time-consuming, limiting their widespread adoption, particularly in low-resource settings. Additionally, the need for high-quality, uncontaminated samples can complicate the process, as even minor contaminations can affect downstream applications like PCR or sequencing. As the market grows, manufacturers face pressure to develop cost-effective and user-friendly solutions that can deliver high yields with minimal contaminants, all while maintaining regulatory compliance and meeting the evolving demands of the genomics and diagnostics sectors.

Global key players of nucleic acid isolation and purification include Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, etc. Global top five manufacturers hold a share over 63%. North America is the largest producer of nucleic acid isolation and purification holds a share over 48%. In terms of product, RNA isolation and purification is the largest segment, with a share over 51%. And in terms of application, the largest application is laboratory, with a share over 73%.

This report presents a comprehensive overview of the global Nucleic Acid Isolation and Purification market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • DNA Isolation and Purification
  • RNA Isolation and Purification

Segment by Application

  • Laboratory
  • Hospital
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Nucleic Acid Isolation and Purification market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Laboratory, Hospital, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Nucleic Acid Isolation and Purification Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.28B
2025
Forecast
$7.9B
2032
CAGR
6%
2025–2032
Regiões
5
global
Key companies
QiagenThermo Fisher ScientificMerck KGaARocheDanaherPerkinElmerAgilentPromega
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
DNA Isolation and PurificationRNA Isolation and Purification
By Application
LaboratoryHospitalOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 DNA Isolation and Purification
  • 3.1.3 RNA Isolation and Purification
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Laboratory
  • 4.1.3 Hospital
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Qiagen
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Thermo Fisher Scientific
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Merck KGaA
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Roche
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Danaher
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 PerkinElmer
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Agilent
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Promega
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Bio-Rad
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Takara Bio
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Kurabo Biomedical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 LGC Biosearch
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Abcam
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Bioneer
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Meridian Bioscience
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 CW Bio
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Xian Tianlong
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Suzhou Yarui
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Shengxiang
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Shanghai Zhijiang
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Nucleic Acid Isolation and Purification market?
The global Nucleic Acid Isolation and Purification market is estimated at US$ 5.28 billion in 2025 (base year) and is projected to reach US$ 7.92 billion by 2032.
What is the forecast CAGR for the Nucleic Acid Isolation and Purification market?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 5.28 billion in 2025 to US$ 7.92 billion in 2032, roughly 1.5 times its base-year value.
What is Nucleic Acid Isolation and Purification?
The isolation and purification of nucleic acid are among the basic tests in the molecular laboratory research, with the availability of a wide range of equipment and processes used for its extraction. Nucleic acid isolation and purification is a combination of chemical and physical processes involved in isolation of DNA or RNA. Nucleic acid isolation and purification used in many types of biological research including molecular biology, forensics, pathology, environmental research, and drug discovery.
How is the Nucleic Acid Isolation and Purification market segmented by type?
By type, the market is segmented into DNA Isolation and Purification and RNA Isolation and Purification.
What are the key applications of Nucleic Acid Isolation and Purification?
Key applications covered include Laboratory, Hospital and Others.
Which companies are profiled in the Nucleic Acid Isolation and Purification market report?
Key players profiled include Qiagen, Thermo Fisher Scientific, Merck KGaA, Roche, Danaher, PerkinElmer, Agilent and Promega, among 20 companies covered in total.
What geographies does the Nucleic Acid Isolation and Purification market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the main risks and barriers in the Nucleic Acid Isolation and Purification market?
Additionally, technological advancements, such as automation, higher throughput systems, and more efficient kits, are improving the speed, sensitivity, and reproducibility of nucleic acid isolation, making these processes more accessible across laboratories and clinical settings.The key challenges in the nucleic acid isolation and purification market is the complexity and cost of the available technologies.
Who should buy the Nucleic Acid Isolation and Purification market report?
The report is intended for manufacturers and solution providers, distributors and end users in Laboratory, Hospital and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Nucleic Acid Isolation and Purification market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.